18.11.2014 Views

Renilla Luciferase Assay System Technical Manual, TM055

Renilla Luciferase Assay System Technical Manual, TM055

Renilla Luciferase Assay System Technical Manual, TM055

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Luminometers<br />

Product<br />

Turner Designs Model TD-20/20 Luminometer<br />

Turner Designs Model TD-20/20 Luminometer with Printer<br />

Turner Designs Model TD-20/20 Luminometer with Single Auto Injector<br />

Turner Designs Model TD-20/20 Luminometer with Dual Auto Injector<br />

Turner Designs Model TD-20/20 Luminometer with Printer<br />

and Dual Auto Injector<br />

Cat.#<br />

E2041<br />

E2051<br />

E2351<br />

E2361<br />

E2061<br />

(a) Patent Pending.<br />

(b) Certain applications of this product may require licenses from others.<br />

(c) U.S. Pat. No. 5,283,179, 5,641,641, 5,650,289, 5,814,471, Australian Pat. No. 649289 and European Pat. No. 0 553 234 have been issued to<br />

Promega Corporation for a firefly luciferase assay method, which affords greater light output with improved kinetics as compared to the conventional<br />

assay. Other patents are pending.<br />

(d) Licensed under U.S. Pat. Nos. 5,292,658, 5,418,155 and other patents.<br />

(e) The CMV promoter and its use are covered under U.S. Pat. Nos. 5,168,062 and 5,385,839 owned by the University of Iowa Research<br />

Foundation, Iowa City, Iowa, and licensed FOR RESEARCH USE ONLY. Commercial users must obtain a license to these patents directly from<br />

the University of Iowa Research Foundation.<br />

(f) U.S. Pat. No. 5,744,320 and Australian Pat. No. 721172 have been issued to Promega Corporation for quenching reagents and assays for<br />

enzyme-mediated luminescence. Other patents are pending.<br />

(g) The cationic lipid component of the TransFast Transfection Reagent is covered by U.S. Pat. Nos. 5,824,812, 5,869, 715 and pending foreign<br />

patents.<br />

(h) Transfectam is a registered trademark of BioSepra, S.A., the holder of a license from CNRS-ULP Strasbourg under U.S. Pat. No. 5,171,678 to<br />

sell the Transfectam ® product for research purposes only. The Transfectam ® product was developed by J.P. Behr and J.P. Loeffler and is covered<br />

by the aforementioned patent.<br />

(i) The cationic lipid component of the Tfx Reagents is covered by U.S. Pat. Nos. 5,527,928, 5,744,625 and 5,892,071, Australian Pat. No.<br />

704189 and other pending foreign patents.<br />

(j) Organizations may use this product in their research and they may transfer derivatives of the product to colleagues at other Nonprofit<br />

Organizations provided that such colleagues agree in writing to be bound by the terms and conditions of this label license. Researchers may<br />

not transfer this product or its derivatives to researchers at other organizations, which are not Nonprofit Organizations, without the express written<br />

consent of Promega and without those entities having an express license from Promega for the use of the product. Other than as specifically<br />

provided here, an authorized transferee of this product shall have no right to transfer this product or its derivatives to any other person or<br />

entity. A Nonprofit Organization means (1) a university or other institution of higher education located in any country; (2) an organization of the<br />

type described in section 501(c)(3) of the Internal Revenue Code of 1954 [26 U.S.C. 501(c)(3)] and exempt from taxation under section 501(a)<br />

of the Internal Revenue Code [26 U.S.C. 501(a)]; or (3) any nonprofit organization located in a foreign country that would qualify as a nonprofit<br />

organization under paragraph (2) of this section if it were located in the United States. Any organization that is not "Nonprofit" as defined here is<br />

considered a for-profit organization. A Nonprofit Organization performing research for a for-profit organization also shall be considered for-profit.<br />

With respect to research use by for-profit organizations, or any diagnostic or therapeutic uses, please contact Promega Corporation for supply<br />

and licensing information.<br />

© 2001 Promega Corporation. All Rights Reserved.<br />

Dual-<strong>Luciferase</strong> and ProFection are trademarks of Promega Corporation and are registered with the U.S. Patent and Trademark Office. Tfx and<br />

TransFast are trademarks of Promega Corporation.<br />

Triton is a registered trademark of Union Carbide Chemicals and Plastics Co., Inc.<br />

All prices and specifications are subject to change without prior notice.<br />

Product claims are subject to change. Please contact Promega <strong>Technical</strong> Services or access the Promega online catalog for the most up-todate<br />

information on Promega products.<br />

Promega Corporation · 2800 Woods Hollow Road · Madison, WI 53711-5399 USA · Toll Free in USA 800-356-9526 · Telephone 608-274-4330 · Fax 608-277-2516 · www.promega.com<br />

Printed in USA.<br />

Part# <strong>TM055</strong><br />

Revised 6/01 Page 13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!